Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection

Sebastiaan J. Hullegie, Brenda C. M. de Winter, Dirk Posthouwer, Peter P. Koopmans, Mark A. A. Claassen, David M. Burger, Bart J. A. Rijnders

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

Original languageEnglish
Pages (from-to)529-530
JournalAids
Volume30
Issue number3
DOIs
Publication statusPublished - 28 Jan 2016

Cite this

Hullegie, S. J., de Winter, B. C. M., Posthouwer, D., Koopmans, P. P., Claassen, M. A. A., Burger, D. M., & Rijnders, B. J. A. (2016). Safety of rilpivirine and boceprevir coadministration in HIV-infected patients treated for acute hepatitis C virus infection. Aids, 30(3), 529-530. https://doi.org/10.1097/QAD.0000000000000950